Public Company News
Acer Refreshes Nitro Lineup with Powerful New PCs and Displays for Casual Gamers
Editor's Summary: * The Acer Nitro V 16 gaming laptop delivers AI-powered performance and impressive visuals with up to an Intel® Core™ 9 processor 270H, NVIDIA® GeForce RTX™ 5070 Laptop GPU, and WQXGA-resolution display with a 180 Hz refresh rate. * The Acer Nitro V 16S is a portable gaming ...
2025-09-03 17:20
1763
Acer Unleashes Predator Helios 18P AI: Hybrid Gaming Laptop for Work and Play
New Predator desktops, monitor, and keyboard deliver elite performance and cutting-edge features for gamers Editor's Summary * The Predator Helios 18P AI laptop leverages advanced hardware and firmware technologies for versatile work and play, with a powerful Intel® Core™ Ultra 9 Processor 28...
2025-09-03 17:15
1467
SK hynix Introduces Industry's First Commercial High NA EUV
- Brings ASML's EXE:5200B, critical system for next-generation chips, to M16 fab - Improved precision, density by 1.7x and 2.9x to help competitive production - Company to lead AI memory with cutting-edge tech required by key industries SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- ...
2025-09-03 07:30
1743
Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program
Milestone European deployment underscores growing global trust in Lunit's AI for population-wide breast cancer screening SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that its solutions h...
2025-09-02 21:00
1947
Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer's disease and Dementia Data
* Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related data * Enhancing dementia research by integrating AI imaging solutions with real-world data platforms SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- Neurophet...
2025-09-02 21:00
2228
Future FinTech Announces Agreement to Develop Advanced Rail Transport System
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Future FinTech Group Inc. (NASDAQ: FTFT; "Future FinTech", "FTFT", or the "Company"), a comprehensive financial and digital technology service provider, today announced that its wholly-owned subsidiary, Future Commercial Group Co. Ltd., has signed a Project...
2025-09-02 20:30
1891
MDJM Announces Opening of Bar at Robin Hill Hotel, Unlocking New Revenue Stream and Enhancing Cultural Hospitality Offering
LETHAM, Scotland, Sept. 2, 2025 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that it had received the final licensing approval on August 19, 2025 and officially opened a new bar on August 19, 2025 a...
2025-09-02 20:30
2064
Hyosung Heavy Industries Strengthens Global Position in Power Solutions Under Chairman Cho Hyun-joon's Leadership
- Chairman Cho Emphasizes Power Infrastructure as Foundation of the AI Economy, Identifies Power Equipment as Next Growth Driver - Hyosung Heavy Industries Signs Significant Power Equipment Supply Contracts Across North America andEurope - Hyosung's Advances in High-Voltage Direct Current (HVDC) T...
2025-09-02 20:30
1930
BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform
XI'AN, China, Sept. 2, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds f...
2025-09-02 20:30
3624
TOYO Co., Ltd to Announce First Half 2025 Financial Results on September 8, 2025
TOKYO, Sept. 2, 2025 /PRNewswire/ -- TOYO Co., Ltd
2025-09-02 20:30
1895
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift
* Approximately 800 children aged 12 months to 12 years in Korea and abroad, aiming for completion by 2027 * Rising demand for 2-dose regimen as international standards amid projected global market growth toUSD 6.3 billion by 3034 * SKBS continues strategic R&D to enhance global vaccine comp...
2025-09-02 19:00
1641
ChipMOS ANNOUNCES NT$480 MILLION SHARE REPURCHASE PROGRAM
HSINCHU, Sept. 2, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC.
("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150
2025-09-02 18:00
2795
China Automotive Systems Announces Special Meeting of Stockholders on September 10, 2025
A special meeting of stockholders will be held on Wednesday, September 10, 2025 , at9:00 AM local time or 9:00 PM EDT on Tuesday, September 9, 2025 WUHAN, China, Sept. 2, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering componen...
2025-09-02 18:00
2785
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
- Ascletis to present data from the U.S. Phase Ib clinical study of ASC30 oral tablet in oral discussion - On track to report topline data from Phase IIa clinical study of ASC30 oral tablet in participants with obesity or overweight in the fourth quarter of 2025 HONG KONG, Sept. 2, 2025 /PRNe...
2025-09-02 18:00
1373
Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights
SHANGHAI, Sept. 2, 2025 /PRNewswire/ -- Peptides have recently emerged at the forefront of therapeutic innovation, with cyclic peptides gaining particular attention for their ability to bridge the gap between small molecules and large biologics. Positioned between the two, cyclic peptides combine...
2025-09-02 17:52
1447
Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy
HONG KONG, Sept. 2, 2025 /PRNewswire/ -- Akeso (9926.HK) has recently announced the completion of patient enrollment in its Phase III, multicenter, randomized, controlled, registrational study evaluating ivonescimab, in combination with standard therapy, against durvalumab (PD-L1) combination the...
2025-09-02 16:00
1349
Infosys Collaborates with Glion Arena Kobe as Official Digital Innovation and GX Partner
Infosys Cobalt to power a smart and sustainable entertainment experience
KOBE, Japan and BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- Infosys
2025-09-02 14:35
2082
AMI Pharm's AYP-101 Shows Promise in Phase 2 Trial, Signaling a Breakthrough in Nonsurgical Fat Reduction
* AMI Pharm's 'AYP-101' Sets to Become a New Leader in Nonsurgical Fat Reduction with Phase 2 Trial Success * 'AYP-101,' a Promising Nonsurgical Solution, Has Its Clinical Results Published in Clinical Therapeutics * 'AYP-101' Demonstrates Superior Safety and Efficacy, Poised to Change the ...
2025-09-01 21:00
1449
Zeekr Group Announces August 2025 Delivery Update
HANGZHOU, China, Sept. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forAugust 2025. In August, Zeekr Group delivered a total of 44,843 v...
2025-09-01 16:00
3104
Jenscare, releases 2025H1 interim results
BEIJING, Sept. 1, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs, achieved milestones in its product portfolio globally, and just released its interim results for 2025H1 endedJune 30, 2025...
2025-09-01 13:00
4919
Week's Top Stories
Most Reposted
One Universal Production Group (OUP) Officially Opens, Reinforcing Its Position as Asia's Leading IP Ecosystem and Tourism Company
[Picked up by 315 media titles]
2025-12-20 09:36
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 297 media titles]
2025-12-23 14:23
The Grand Opening of Dreame Hong Kong Flagship Store Showcases Full Product Lineup
[Picked up by 270 media titles]
2025-12-21 12:42
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 269 media titles]
2025-12-26 12:55Fijian and Chinese Scholars Gather to Discuss Bilateral Friendship and the Outlook for APEC 2026
[Picked up by 263 media titles]
2025-12-22 15:56
